A detailed history of Harbor Capital Advisors, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 7,503 shares of BIO stock, worth $2.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,503
Previous 3,663 104.83%
Holding current value
$2.5 Million
Previous $1 Million 151.0%
% of portfolio
0.11%
Previous 0.08%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$263.97 - $344.64 $1.01 Million - $1.32 Million
3,840 Added 104.83%
7,503 $2.51 Million
Q2 2024

Jul 09, 2024

BUY
$268.26 - $339.48 $748,981 - $947,828
2,792 Added 320.55%
3,663 $1 Million
Q1 2024

May 13, 2024

BUY
$304.11 - $351.99 $264,879 - $306,583
871 New
871 $301,000
Q3 2023

Oct 20, 2023

SELL
$350.25 - $422.63 $40,629 - $49,025
-116 Reduced 9.46%
1,110 $397,000
Q2 2023

Jul 11, 2023

BUY
$359.49 - $486.4 $1,078 - $1,459
3 Added 0.25%
1,226 $464,000
Q1 2023

Apr 26, 2023

SELL
$418.69 - $503.0 $50,242 - $60,360
-120 Reduced 8.94%
1,223 $585,000
Q4 2022

Jan 20, 2023

SELL
$351.71 - $456.01 $10,199 - $13,224
-29 Reduced 2.11%
1,343 $0
Q3 2022

Oct 28, 2022

SELL
$412.59 - $563.26 $63,126 - $86,178
-153 Reduced 10.03%
1,372 $572,000
Q2 2022

Jul 26, 2022

SELL
$463.67 - $597.16 $15,764 - $20,303
-34 Reduced 2.18%
1,525 $755,000
Q1 2022

Apr 28, 2022

BUY
$524.57 - $735.42 $25,703 - $36,035
49 Added 3.25%
1,559 $878,000
Q4 2021

Feb 04, 2022

BUY
$708.84 - $794.68 $1.07 Million - $1.2 Million
1,510 New
1,510 $1.14 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.